Related Experiment Video
Updated: Mar 13, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Clinical course and outcomes of childhood-onset granulomatosis with polyangiitis
Karen E James1, Rui Xiao2, Peter A Merkel3
1Division of Rheumatology, Department of Paediatrics, Children's Hospital of Philadelphia, PA, USA. karenejames24@gmail.com.
Insights
Pediatric granulomatosis with polyangiitis (GPA) often presents severely, impacting kidneys and GI tract. While remission is common, nearly half of children with GPA experience relapses, highlighting the need for ongoing management.
Area of Science:
- Pediatric Rheumatology
- Vasculitis Research
- Clinical Immunology
Background:
- Granulomatosis with polyangiitis (GPA) is a rare autoimmune vasculitis affecting children.
- Understanding the clinical course and outcomes in pediatric GPA is crucial for effective management.
Purpose of the Study:
- To characterize the clinical presentation, disease course, and long-term outcomes in a cohort of children diagnosed with GPA.
- To identify predictors of readmission and relapse in pediatric GPA patients.
Main Methods:
- Retrospective cohort study of 28 children diagnosed with GPA between 2000-2014.
- Utilized American College of Rheumatology (1990) and EULAR/PReS (2008) criteria for diagnosis.
- Employed logistic regression for readmission predictors and Kaplan-Meier analysis for relapse-free survival.
Main Results:
- Half of the children required intensive care at presentation; significant renal, respiratory, and gastrointestinal involvement was common.
- Two-thirds of patients were readmitted, primarily due to renal failure and infections.
- While 85% achieved remission, 11 patients relapsed, with hematuria at diagnosis predicting readmission.
Conclusions:
- Pediatric GPA frequently presents with severe systemic involvement, particularly affecting the kidneys.
- Despite high initial remission rates, nearly half of children with GPA experience relapses, underscoring the chronic nature of the disease.
Objectives:
To characterise the clinical course and outcomes of a cohort of children with granulomatosis with polyangiitis (GPA).
Methods:
Retrospective cohort study of children diagnosed with GPA in a tertiary care facility from 2000-2014. All subjects met the American College of Rheumatology 1990 criteria for GPA or the 2008 European League against Rheumatism/Paediatric Rheumatology International Trials Organisation/Paediatric Rheumatology European Society criteria for GPA. Predictors of readmission were determined using univariate logistic regression. Kaplan-Meier analysis was used to demonstrate the relapse-free survival probability in follow-up.
Results:
Twenty-eight children (median age 14.7 years) were diagnosed during the study period. At presentation 14 (50%), 5 (18%), and 4 (14%) children required intensive care unit care, ventilator support, and dialysis, respectively. One-third of the children in our cohort had gastrointestinal involvement, one-quarter of whom were previously diagnosed with inflammatory bowel disease. Two-thirds of children were readmitted. Renal failure and infections accounted for most readmissions. Twenty-three (85%) patients achieved remission, however, 11 subsequently flared (median time to flare 21.5 months). Haematuria at diagnosis was significantly associated with readmission (OR 6.25). At a median follow-up of 3.3 years (range 5 months to 6 years) 10 (37%) children had chronic kidney disease (> stage 2) and none of the children died.
Conclusions:
Children with GPA frequently have severe disease presentations including significant renal, respiratory and gastrointestinal involvement. While most children with GPA achieve remission, nearly half have subsequent relapses.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome II : Assessment and Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Pyelonephritis I: Introduction
Chronic Kidney Disease II: Clinical Manifestations